Compare Honest Company Inc (HNST) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honest Company Inc vs Illumina, Inc. — how do they compare? Honest Company Inc trades at $4.99 (market cap $533.20M), while Illumina, Inc. trades at $272.08 (market cap $39.95B). The key difference: Illumina, Inc. is far larger — about 74.9× Honest Company Inc's market cap, and Illumina, Inc. is trading nearer its 52-week high, Honest Company Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Honest Company Inc for 39 Days and Illumina, Inc. for 83 Days on average.
| HNST | ILMN | |
|---|---|---|
Market Cap | $533.20M | $39.95B |
Volume | 1,990,155 | 3,169,503 |
Sector | Consumer Staples | Health |
52-Week High | $5.95 | $293.69 |
52-Week Low | $2.10 | $91.00 |
Typical Hold Time | 39 Days | 83 Days |
Enterprise Value | $436.81M | $41.31B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HNST trades at $4.93, down 1.99% today, with a bearish technical outlook despite recent earnings beat. The company shows mixed fundamentals with negative net income margin (-3.56%) and ROE (-6.87%), though Q2 2026 EPS of $0.04 exceeded expectations. Revenue declined to $371M in 2025, but operating cash flow improved to $15.1M. Analyst consensus is mixed with 30% buy ratings and $5.30 price target.
The stock faces headwinds from profitability challenges and competitive pressures, though strategic exits show early signs of margin improvement. Upside potential exists if the company sustains recent operational improvements, but investors should weigh the high P/E ratio of 48.83 against ongoing net losses.
Illumina (ILMN) trades at $271.02, up 1.22% and near its 52-week high, reflecting strong momentum. The stock exhibits a bullish technical trend with recent earnings beats and a positive analyst consensus. Revenue for 2025 was $4.34B with net income of $850M, marking a significant profit margin recovery. Cash flow from operations remains robust at $1.08B, supporting financial stability. Inclusion in the S&P 500 and focus on AI-driven genomics growth are key catalysts.
Outlook is positive given earnings momentum and strategic initiatives, but risks include valuation premiums and competitive pressures. The stock offers growth exposure to genomic innovation, though investors should monitor execution on AI integration and margin sustainability. Analyst price targets suggest moderate upside from current levels, with consensus at $241.00.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Honest Company Inc
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
